文献速递肝病

肝脏基质细胞限制巨噬细胞成熟且基质来源IL-6限制肝硬化相关巨噬细胞分化

Liver stromal cells restrict macrophage maturation and stromal IL-6 limits the differentiation of cirrhosis-linked macrophages.
PubMed 文献 · J Hepatol · 2022-01-21

本研究通过单细胞RNA测序分析非肝硬化(n=7)与肝硬化(n=5)人肝组织,并结合体外共培养体系,发现肝脏基质细胞抑制单核细胞向巨噬细胞成熟,且基质来源IL-6限制肝硬化相关CD9+巨噬细胞样细胞分化;早期肝病局部IL-6水平较健康肝组织降低。

要点

  • 基质-髓系共培养降低转录上类似肝巨噬细胞的CD14+细胞亚群频率,提示基质细胞抑制单核细胞成熟。
  • 基质细胞使体外巨噬细胞分化偏离肝硬化相关CD9+瘢痕相关巨噬细胞样细胞,转向CD163+库普弗细胞样巨噬细胞。
  • IL-6是基质细胞限制CD9+巨噬细胞分化的机制之一,早期人肝病局部IL-6水平较健康肝组织降低。

核心结论

  • 肝脏基质细胞在阻碍巨噬细胞成熟和改变其分化中具有此前未预期的作用,应推动对局部IL-6产生在肝病发病机制中作用的研究。

研究设计与样本

  • 对非肝硬化(n=7)与肝硬化(n=5)人肝组织进行单细胞RNA测序分析。
  • 将上述结果与体外共培养的人CD14+细胞和原代肝基质细胞的bulk RNA测序结果进行关联。
  • 在人肝基质-髓系共培养体系中进行补充的机制实验和流式细胞术分析。

主要发现

  • 基质-髓系共培养降低转录上类似肝巨噬细胞的CD14+细胞亚群频率,表明基质细胞抑制单核细胞向巨噬细胞成熟。
  • 基质细胞使体外巨噬细胞分化偏离肝硬化相关CD9+瘢痕相关巨噬细胞样细胞,转向CD163+库普弗细胞样巨噬细胞。
  • 鉴定出IL-6产生是基质细胞限制CD9+巨噬细胞分化的机制。
  • 早期人肝病局部IL-6水平较健康肝组织降低,提示局部IL-6在健康肝脏中可能具有保护作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Myeloid cells are key regulators of cirrhosis, a major cause of mortality worldwide. Because stromal cells can modulate the functionality of myeloid cells in vitro, targeting stromal-myeloid interactions has become an attractive potential therapeutic strategy. We aimed to investigate how human liver stromal cells impact myeloid cell properties and to understand the utility of a stromal-myeloid coculture system to study these interactions in the context of cirrhosis. METHODS: Single-cell RNA-sequencing analyses of non-cirrhotic (n = 7) and cirrhotic (n = 5) human liver tissue were correlated to the bulk RNA-sequencing results of in vitro cocultured human CD14+ and primary liver stromal cells. Complimentary mechanistic experiments and flow cytometric analysis were performed on human liver stromal-myeloid coculture systems. RESULTS: We found that stromal-myeloid coculture reduces the frequency CD14+ cell subsets transcriptionally similar to liver macrophages, showing that stromal cells inhibit the maturation of monocytes into macrophages. Stromal cells also influenced in vitro macrophage differentiation by skewing away from cirrhosis-linked CD9+ scar-associated macrophage-like cells and towards CD163+ Kupffer cell-like macrophages. We identify IL-6 production as a mechanism by which stromal cells limit CD9+ macrophage differentiation and find that local IL-6 levels are decreased in early-stage human liver disease compared to healthy liver tissue, suggesting a protective role for local IL-6 in the healthy liver. CONCLUSIONS: Our work reveals an unanticipated role for liver stromal cells in impeding the maturation and altering the differentiation of macrophages and should prompt investigations into the role of local IL-6 production in the pathogenesis of liver disease. These studies provide a framework for investigating macrophage-stromal interactions during cirrhosis. LAY SUMMARY: The impact of human liver stromal cells on myeloid cell maturation and differentiation in liver disease is incompletely understood. In this study, we present a mechanistic analysis using a primary in vitro human liver stromal-myeloid coculture system that is translated to liver disease using single-cell RNA sequencing analysis of cirrhotic and non-cirrhotic human liver tissue. Our work supports a role for stromal cell contact in restricting macrophage maturation and for stromal-derived IL-6 in limiting the differentiation of a cirrhotic macrophage subset.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Buonomo EL, Mei S, Guinn SR, et al. Liver stromal cells restrict macrophage maturation and stromal IL-6 limits the differentiation of cirrhosis-linked macrophages. J Hepatol. 2022. PMID: 35074474. doi:10.1016/j.jhep.2021.12.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。